Lonsurf trifluridine/tipiracil: Phase III data

The double-blind, Asian Phase III TERRA trial in 406 mCRC patients who were refractory to or failed >=2 prior chemotherapies showed that twice-daily 35 mg/m 2 oral TAS-102 on days 1-5 and 8-12 of a 28...